Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

313.50p
   
  • Change Today:
    -0.50p
  • 52 Week High: 445.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.09m
  • Volume: 25,527
  • Market Cap: £332.60m
  • RiskGrade: 125
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
79.24% above the market average79.24% above the market average79.24% above the market average79.24% above the market average79.24% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
4.95% above the market average4.95% above the market average4.95% above the market average4.95% above the market average4.95% above the market average
15.38% below the sector average15.38% below the sector average15.38% below the sector average15.38% below the sector average15.38% below the sector average
Price Book Ratio
81.46% below the market average81.46% below the market average81.46% below the market average81.46% below the market average81.46% below the market average
43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
40.55% above the market average40.55% above the market average40.55% above the market average40.55% above the market average40.55% above the market average
43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average
Price Chg 3m
1.57% above the market average1.57% above the market average1.57% above the market average1.57% above the market average1.57% above the market average
21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
12.15% above the market average12.15% above the market average12.15% above the market average12.15% above the market average12.15% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Momentum 20
50.40% above the market average50.40% above the market average50.40% above the market average50.40% above the market average50.40% above the market average
76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
65.38% below the market average65.38% below the market average65.38% below the market average65.38% below the market average65.38% below the market average
18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
96.13% below the market average96.13% below the market average96.13% below the market average96.13% below the market average96.13% below the market average
95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
27.68% above the market average27.68% above the market average27.68% above the market average27.68% above the market average27.68% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Operating Profit Loss
94.99% below the market average94.99% below the market average94.99% below the market average94.99% below the market average94.99% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
46.47% above the market average46.47% above the market average46.47% above the market average46.47% above the market average46.47% above the market average
54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average
Cash
57.79% above the market average57.79% above the market average57.79% above the market average57.79% above the market average57.79% above the market average
64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
44.12% below the market average44.12% below the market average44.12% below the market average44.12% below the market average44.12% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
51.04% below the market average51.04% below the market average51.04% below the market average51.04% below the market average51.04% below the market average
62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average
Brokers Percent Neutral
39.34% above the market average39.34% above the market average39.34% above the market average39.34% above the market average39.34% above the market average
Sector averageSector averageSector averageSector averageSector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 313.50p
Change Today -0.50p
% Change -0.16 %
52 Week High 445.00
52 Week Low 232.50
Volume 25,527
Shares Issued 106.09m
Market Cap £332.60m
Beta 0.00
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.54% below the market average29.54% below the market average29.54% below the market average29.54% below the market average29.54% below the market average
21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average
Price Trend
53.29% below the market average53.29% below the market average53.29% below the market average53.29% below the market average53.29% below the market average
4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average
Income Not Available
Growth
3.15% above the market average3.15% above the market average3.15% above the market average3.15% above the market average3.15% above the market average
9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 19-Jun-2025

Time Volume / Share Price
16:35 6,530 @ 313.50p
16:35 443 @ 313.50p
16:35 20 @ 313.50p
16:35 7 @ 313.50p
16:35 23 @ 313.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page